Picture of Sangamo Therapeutics logo

SGMOQ Sangamo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Sangamo Therapeutics Q1 Operating Income USD -51.526 Million

May 09 (Reuters) - Sangamo Therapeutics Q1 net income USD -49.089 million.
* Q1 adjusted operating expenses USD 43.6 million
* Q1 operating expenses USD 52 million
* Q1 revenue USD 481 thousand vs. IBES estimate USD 6.65 million

Recent news on Sangamo Therapeutics

See all news